|
|
|
|
International Stem Cell Using New Funding to Retire Debt
International Stem Cell, an Oceanside-based company that derives human stem cell lines from unfertilized human eggs, said Dec.30 that it received the first $1 million of $5 million in private equity financing. The remainder, to be...
|
|
|
Law Firm Courts Biotech Startups For Booster Shot
Small paper signs tacked outside doorways hint of new occupants at the Carmel Valley law firm of Pillsbury Winthrop Shaw and Pittman.But the latest tenants to share space within the glassy confines of Suite 300 don't pay rent. They aren...
|
|
|
What's Ahead in '09
Steve Doyle, president, Brookfield Homes The good news for today is that new home inventories are down dramatically.Resale inventories are down dramatically and home sales are up significantly. Sales of foreclosures exceed new homes...
|
|
|
More Cutbacks Likely for Cash-Strapped Biotechs
Jeanne Loring Cash-strapped biotechnology firms will continue to seek new avenues for cutting costs and raising money in the New Year, industry analysts said.Many said they expect San Diego to fare well over the long term.'I do think San...
|
|
|
Pfizer Inks Deal With Novocell
Novocell, a San Diego-based company developing stem cell treatments for diabetes, said it signed a two-year deal that will give pharmaceutical giant Pfizer access to its insulin-producing pancreatic cells derived from human embryonic stem...
|
|
|
Big Pharma Deal May Deliver $163M, Plus Royalties, to Ligand
San Diego-based Ligand Pharmaceuticals said Dec.18 that it granted GlaxoSmithKline exclusive rights to its experimental thrombocytopenia drug, used to treat low platelet levels, in a deal valued at $163 million plus royalties. Under...
|
|
|
Novocell to Collaborate on Diabetes Treatment
San Diego-based stem cell engineering company Novocell said Dec.9 it will collaborate with renowned Japanese researcher Shinya Yamanaka of Kyoto University to push forward stem cell treatments for type 1 diabetes. As a senior...
|
|
|
In the Lab
Peter Linsley is chief scientific officer at Regulus Therapeutics.His researchers have demonstrated that they can reverse heart failure in mice by treating the rodents with an experimental gene-silencing drug. A partnership forged...
|
|
|
Artes Medical Files for Bankruptcy
Artes Medical, a San Diego biotechnology company that makes a permanent wrinkle filler for so-called smile lines, filed for Chapter 7 bankruptcy protection Dec.Plans call for liquidating the business, according to bankruptcy documents...
|
|
|
Artes Files for Chapter 7
Artes Medical, a San Diego biotechnology company that makes a permanent wrinkle filler for so-called 'smile lines,' filed for Chapter 7 bankruptcy protection Dec.It will liquidate the business, the company said in bankruptcy documents...
|
